Biodesix Inc. (BDSX) Reports In-Line Q1 EPS

Biodesix Inc. (NASDAQ: BDSX) reported Q1 EPS of ($0.24), in-line with the analyst estimate of ($0.24). Revenue for the quarter came in at $9.05 million versus the consensus estimate of $11.39 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c